Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden

Size: px
Start display at page:

Download "Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden"

Transcription

1 2010 Bilcare Technologies. Privileged presentation, slide 1 Singular ID The Story of Commercialising a Materials Technology in Singapore Adrian Burden Co-founding Director of Singular ID President Europe of Bilcare Technologies

2 2010 Bilcare Technologies. Privileged presentation, slide 2 Overview My background Phase 1 R&D Materials R&D project and applications Proof-of-principle Business Planning Phase 2 spinning-off Venture capital finance & operations First customer & manufacturing partners Phase 3 - growth Overseas expansion, new applications Product launch, further financing Phase 4 exit Acquisition New opportunities and future prospects

3 2010 Bilcare Technologies. Privileged presentation, slide 3 My background MA Cantab, University of Cambridge Natural Sciences (materials) D.Phil. Oxon, University of Oxford Department of materials, electron microscopy of carbon Founding President of the OU lifesaving club Raychem Ltd, UK Corporate R&D, conductive polymer composites University of Surrey, UK Post doctoral research amorphous carbon films Printable Field Emitters Ltd, UK R&D Manager field emission display technology Institute of Materials Research & Engineering (IMRE) Senior Scientist and Business Development Manager OLED technology, ON-Singapore & Technology Roadmapping Singular ID Pte Ltd Founding CEO Bilcare Technologies President, Europe

4 2010 Bilcare Technologies. Privileged presentation, slide 4 Phase 1 R&D

5 2010 Bilcare Technologies. Privileged presentation, slide 5 Phase 1 the R&D project Singapore R&D Project IMRE / A-STAR

6 2010 Bilcare Technologies. Privileged presentation, slide 6 Phase 1 the R&D project Magnetic hard disk drive technology Quest for ever-denser information storage In-plane to out-of-plane magnetic bits Materials R&D nanotechnology of candidate films Highly regular and uniform disk media very difficult! Image source: Hitachi Global Storage Technologies

7 2010 Bilcare Technologies. Privileged presentation, slide 7 Phase 1 the passport analogy Passport number Serial # or index # Makes searching a database quick and easy Photograph, signature or fingerprint The security / biometric Giving products fingerprints Materials fingerprint The security feature Cannot be replicated Barcode Serial # or index # Makes searching a database quick and easy

8 2010 Bilcare Technologies. Privileged presentation, slide 8 Phase 1 applications: the problem of counterfeits Authorised distribution Grey market diversion Impact on Brand Owner Lower margins Unforeseen liabilities Distribution license issues Brand owner R&D $ Quality Testing Authorised factory Product overruns Lost revenues Over supply Increased warranty claims Lower margins Counterfeit products Lost revenues Increased warranty claims Brand erosion Product liabilities Copycat factory Interpol estimates 5-7% of world trade involves counterfeits This is equivalent to over USD 500 billion in lost sales

9 2010 Bilcare Technologies. Privileged presentation, slide 9 Phase 1 leading to a proof-of-principle Credit cards and paper with fingerprint tag Scanner with sensor and electronics Mobile phone and software Back-end database

10 2010 Bilcare Technologies. Privileged presentation, slide 10 Phase 1 R&D - Highlights Proof of Principle Publicity Singular ID Market Research Business Plan License Agreement Explaining the technology to the President of Singapore Signing of the license agreement

11 2010 Bilcare Technologies. Privileged presentation, slide 11 Phase 1 - our toolbox Laboratory log books Travellers / process control TRAV 1.1, 2.1, etc First-cut roadmap Non-Disclosure Agreements Executive Summary EXEC 1.1, 1.2, etc Business Plan Information sheets Presentation License Agreement (and benchmarks)

12 2010 Bilcare Technologies. Privileged presentation, slide 12 Phase 1 - our first-cut roadmap Mid 2005 Spin-off Market trends Finance & Revenue Infrastructure Accreditation Staff Revenue Materials Tag Scanner Dispenser Database

13 2010 Bilcare Technologies. Privileged presentation, slide 13 Phase 1 looking back What we did well Kept detailed records of all work and correspondence Created an internal shared IT resource Used government funding to create a proof-of-principle Filed 2 patents that became a good foundation Negotiated a fair / rigorous license agreement Started some early branding & publicity Where we could have done better Secured venture finance before spinning-off Found a customer before spinning-off Had a more relevant hand-held prototype device

14 2010 Bilcare Technologies. Privileged presentation, slide 14 Phase 2 Spinning Off

15 2010 Bilcare Technologies. Privileged presentation, slide 15 Phase 2 spinning-off & starting operations Singapore R&D Project IMRE / A-STAR Spin-off company 1 st runner-up finalist winner Series A Acquired by Bilcare

16 2010 Bilcare Technologies. Privileged presentation, slide 16 Phase 2 - why Singapore? Universities & Research Institutes Incubators & Science Parks National infrastructure & capability Basic research Platform technology Prototypes Business development Supply chain integration Scale-up & manufacturing Application driven Sales Overseas Marketing & growth R&D Start-up IT & IP generation Logistics equipment community infrastructure Business Corporate Education R&D grants acumen governance

17 2010 Bilcare Technologies. Privileged presentation, slide 17 Phase 2 why Singapore? R&D Science, Engineering, Biomedical Applied research and enhancement schemes Economic development Attracting MNCs, supporting SMEs Standards and Productivity Supports technology and commerce International Enterprise Overseas expansion and branding Infocomm Development IT and infrastructure focused Other agencies and organisations play important roles too

18 2010 Bilcare Technologies. Privileged presentation, slide 18 Phase 2 Spinning off - Highlights Investment from Advance Nanotech Winner of Major Business Plan Competition Production Partners Product Development

19 2010 Bilcare Technologies. Privileged presentation, slide 19 Phase 2 our operational model Leveraging on alliances Channel Marketing Joint ventures Brand security companies IT Platform companies Customers Singular ID IP & Systems Integration Out-sourcing & partnerships Established hardware suppliers Scanner contract manufacturers Tag and Label contract manufacturers Data management Internet & Mobile service providers

20 2010 Bilcare Technologies. Privileged presentation, slide 20 Phase 2 lucky break

21 2010 Bilcare Technologies. Privileged presentation, slide 21 Phase 2 our toolbox Company templates NDAs, Travellers, etc Employment contracts Accounting package (Excel to start!) Term sheets / Investment Agreements Letter Agreements PO system, Invoice system, CRM Budget sheets Board Reports Server

22 2010 Bilcare Technologies. Privileged presentation, slide 22 Phase 2 looking back What we did well Moved into presentable incubation premises Generated publicity Secured venture finance Obtained a customer and had focus Watched the cash flow carefully Secured a government R&D grant Won a significant business plan competition Where we could have done better Secured a bit more finance Captured more of the lower end of the market Added a more senior member to our team earlier on Used a good accounting package early on

23 2010 Bilcare Technologies. Privileged presentation, slide 23 Phase 3 Growth

24 2010 Bilcare Technologies. Privileged presentation, slide 24 Phase 3 growth Padua, Italy Singapore R&D Project IMRE / A-STAR Spin-off company winner 1 st runner-up finalist winner Series A Acquired by Bilcare

25 2010 Bilcare Technologies. Privileged presentation, slide 25 Phase 3 - our first customer Sanden, air-conditioning compressor Sanden Non-Sanden

26 2010 Bilcare Technologies. Privileged presentation, slide 26 Phase 3 Sanden s production line

27 2010 Bilcare Technologies. Privileged presentation, slide 27 Phase 3 - fashion & luxury sector Partnership with Euromark to make enxure labels for the European luxury goods segment Euromark overview holds about 30% market share of labels for European handbags and clothing Current status Identified European launch customer Labels passed all customer s testing to date

28 2010 Bilcare Technologies. Privileged presentation, slide 28 Phase 3 - no to fakes Visit for more information about fake products As a brand owner you can connect with customers using our hosted page service

29 2010 Bilcare Technologies. Privileged presentation, slide 29 Phase 3 Growth - Highlights Minister of State for Trade & Industry, Singapore, attended product launch Awards New Investors Launch Customer

30 2010 Bilcare Technologies. Privileged presentation, slide 30 Phase 3 our toolbox Accounting package (MYOB) More term sheets / Investment Agreements Detailed due diligence directories Extensive warrants and disclosures Product literature & user manuals EULAs and other Terms & Conditions Patents, trademarks, domain names management Publicity archive Permanent exhibits

31 2010 Bilcare Technologies. Privileged presentation, slide 31 Phase 3 looking back What we did well Continued to keep the information flowing Had serious acquisition discussions Used students to keep the cost down Launched a product Continued to watch the cash flow Secured another government R&D grant Where we could have done better Been less distracted by range of commercial opportunities Raised money overseas more quickly Organised our IT system ahead of future staff expansion

32 2010 Bilcare Technologies. Privileged presentation, slide 32 Phase 4 Exit and the future

33 2010 Bilcare Technologies. Privileged presentation, slide 33 Phase 4 Exit and the future R&D Project IMRE / A-STAR Spin-off company Bilcare company winner 1 st runner-up finalist winner Series A Acquired by Bilcare

34 2010 Bilcare Technologies. Privileged presentation, slide 34 Phase 4 - Bilcare

35 2010 Bilcare Technologies. Privileged presentation, slide 35 Phase 4 Highlights Rebranding and new marketing material New range of products The nonclonable TM system More awards

36 2010 Bilcare Technologies. Privileged presentation, slide 36 Phase 4 - the future Bluetooth nonclonable reader Scan then touch Phone, PDA, laptop, PC Results via GPRS / internet nonclonable label DataMatrix & fingerprint combined

37 2010 Bilcare Technologies. Privileged presentation, slide 37 Overall - looking back Positive Our technology is defect tolerant Singapore was an excellent place to start a business We had a clear vision and stayed focused We learnt a huge amount in a short space of time We kept the news flowing Negative Raising early stage funding for high technology was extremely difficult There are lots of balls in the air when you run a technology start-up. You need to quickly learn to juggle!

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.

More information

Authentication Solution for Currency Management

Authentication Solution for Currency Management Bilcare Technologies is a division of Bilcare Ltd. focused on creating next-generation anti-counterfeiting, security, and brand protection solutions for a broad range of industry sectors. With breakthrough

More information

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence

More information

2019 Application Form

2019 Application Form Please send completed forms to pioneers@bloomberg.net THE DEADLINE FOR APPLICATION IS FRIDAY, OCTOBER 26, 2018. Thank you for applying for the New Energy Pioneers Award. Non-disclosure agreement (NDA)

More information

Creata Business Ventures Limited. Investment Opportunities

Creata Business Ventures Limited. Investment Opportunities Creata Business Ventures Limited Investment Opportunities CEO / Founder of Creata Business Ventures Limited Creata Business Ventures Limited Overview Group Company Brand /IP Rights Contracts Transformation

More information

RAISING PRIVATE FINANCE IN THE WATER SECTOR: TRENDS & EXAMPLES. Helping SME s bring ideas to market Fiona Griffith 11 October 2016

RAISING PRIVATE FINANCE IN THE WATER SECTOR: TRENDS & EXAMPLES. Helping SME s bring ideas to market Fiona Griffith 11 October 2016 RAISING PRIVATE FINANCE IN THE WATER SECTOR: TRENDS & EXAMPLES Helping SME s bring ideas to market Fiona Griffith 11 October 2016 Introduction What are the needs? 01/11/2016 isleutilities.com 3 Water Innovators

More information

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017 Cherry AB Investing in a broad gaming portfolio CEO Anders Holmgren GP Bullhound 6 December 2017 The game is on Cherry is investing in a broad portfolio of online gaming companies Cherry s strategy is

More information

IP and Technology Management for Universities

IP and Technology Management for Universities IP and Technology Management for Universities Yumiko Hamano Senior Program Officer WIPO University Initiative Innovation and Technology Transfer Section, Patent Division, WIPO Outline! University and IP!

More information

Opportunities and Innovation in ICT / Emerging trends & industries

Opportunities and Innovation in ICT / Emerging trends & industries Euromed Business Opportunities Title of the presentation Date # Opportunities and Innovation in ICT / Emerging trends & industries Jihene MAKNI : PHD business administration responsible for development

More information

Chapter 5. Forms of Business Ownership and Organization

Chapter 5. Forms of Business Ownership and Organization Chapter 5 Forms of Business Ownership and Organization Learning Objectives 1 2 Discuss why most businesses are small businesses. Determine the contributions of small businesses to the economy. 7 Outline

More information

University IP and Technology Management. University IP and Technology Management

University IP and Technology Management. University IP and Technology Management University IP and Technology Management Yumiko Hamano WIPO University Initiative Program Innovation Division WIPO WIPO Overview IP and Innovation University IP and Technology Management Institutional IP

More information

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector

More information

Commercialization Strategies that Work

Commercialization Strategies that Work Commercialization Strategies that Work Jenny C. Servo, Ph.D. DAWNBREAKER (585)594-0025 DAWNBREAKER Professional Services firm - Rochester, NY Worked with over 1200 SBIR/STTR firms - Department of Energy,

More information

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

CDP-EIF ITAtech Equity Platform

CDP-EIF ITAtech Equity Platform CDP-EIF ITAtech Equity Platform New financial instruments to support technology transfer in Italy TTO Circle Meeting, Oxford June 22nd 2017 June, 2017 ITAtech: the "agent for change" in TT landscape A

More information

Working with SMEs on projects

Working with SMEs on projects Working with SMEs on projects Working with SMEs in Horizon 2020 Horizon 2020 covers the entire innovation cycle, from basic research to introducing the product to the market (FTI Pilot) and therefore,

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

MONTHLY REPORT JUNE 2018 XTPL S.A. Wrocław, r.

MONTHLY REPORT JUNE 2018 XTPL S.A. Wrocław, r. MONTHLY REPORT JUNE 2018 XTPL S.A. Wrocław, 13.07.2018 r. 1. INFORMATION ON ISSUE OBJECTIVES AND OTHER SIGNIFICANT EVENTS IN THE REPORTING PERIOD a. SUMMARY OF ACTIVITIES OF THE ISSUER S BUSINESS DEVELOPMENT

More information

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Moving from Nano-Ideas to Nanomanufacturing. Alan Rae February 2008

Moving from Nano-Ideas to Nanomanufacturing. Alan Rae February 2008 Moving from Nano-Ideas to Nanomanufacturing Alan Rae February 2008 Topics What s different in nanomanufacturing? Technology development and acquisition Commercialization issues Some examples of products

More information

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc. An innovative new system for Supply Chain Financing that is so disruptive that it will revolutionize the way in which practices in B2B trading relationships occur. has invented a system that revolutionizes

More information

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants Topic 12 Managing IP in Public-Private Partnerships, Strategic Alliances,

More information

Private Equity Market and Trends Brigitte Baumann CEO Go Beyond; President of EBAN

Private Equity Market and Trends Brigitte Baumann CEO Go Beyond; President of EBAN WWW.GO-BEYOND.BIZ Private Equity Market and Trends Brigitte Baumann CEO Go Beyond; President of EBAN Going International: EOS 1 st Annual Confernece Brigitte.baumann@go-beyond.biz Soph November 30, 2009

More information

Contents. 1 Introduction... 1

Contents. 1 Introduction... 1 Contents 1 Introduction... 1 Part I Startup Funding Sources, Stages of the Life Cycle of a Business, and the Corresponding Intellectual Property Strategies for Each Stage 2 Sources of Company Funding...

More information

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities

ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities Paul Witcombe Enterprise and Innovation Manager Hertfordshire LEP Email: paul.witcombe@hertfordshirelep.co.uk Tel: 07500 882000 STRUCTURE

More information

University Technology Transfer, Innovation Ecosystem and EIE Project

University Technology Transfer, Innovation Ecosystem and EIE Project University Technology Transfer, Innovation Ecosystem and EIE Project Yumiko Hamano IP Consultant - IP Commercialization Partner, ET Cube International About Me 27+ years at World Intellectual Property

More information

Intellectual Property Management - How to capture, protect and exploit your ideas

Intellectual Property Management - How to capture, protect and exploit your ideas Intellectual Property Management - How to capture, protect and exploit your ideas 13 th February 2013 Gillian Davis & Julian Peck Cambridge Enterprise Limited, University of Cambridge Overview Disclosure

More information

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

BUILDING DIGITAL SKILLS A DIGITAL EUROPE NEEDS DIGITAL SKILLS

BUILDING DIGITAL SKILLS A DIGITAL EUROPE NEEDS DIGITAL SKILLS BUILDING DIGITAL SKILLS A DIGITAL EUROPE NEEDS DIGITAL SKILLS BUILDING DIGITAL SKILLS THROUGHOUT EUROPE Europeans increasingly need to have the skills required for today s digital economy. Europe needs

More information

Het belang van IP voor Venture Capital Backed bedrijven

Het belang van IP voor Venture Capital Backed bedrijven Het belang van IP voor Venture Capital Backed bedrijven Marc Lambrechts, Capricorn Venture Partners 24 april 2018 Arnold & Siedsma Your speaker today : Marc Lambrechts R&D in microsystems and PhD on biosensors

More information

Technology Leadership Course Descriptions

Technology Leadership Course Descriptions ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills

More information

The Intellectual Property, Knowledge Transfer: Perspectives

The Intellectual Property, Knowledge Transfer: Perspectives 1 The Intellectual Property, Knowledge Transfer: Perspectives Salvatore Amico Roxas Intellectual Property & Technology Transfer Unit European Commission - Joint Research Centre Salvatore.amico-roxas@ec.europa.eu

More information

What is InnovFin Equity?

What is InnovFin Equity? What is InnovFin Equity? InnovFin Equity managed by EIF is part of InnovFin EU Finance for Innovators, an initiative launched by the European Commission and the EIB Group in the framework of Horizon 2020.

More information

The role of university science parks in business-university research collaboration

The role of university science parks in business-university research collaboration The role of university science parks in business-university research collaboration The Dowling Review: enhancing business-university research collaboration Dr Malcolm Parry OBE, Director and CEO The Surrey

More information

COLLABORATIVE R&D & IP ISSUES IN TECHNOLOGY TRANSFER IN UNIVERSITY SYSTEM

COLLABORATIVE R&D & IP ISSUES IN TECHNOLOGY TRANSFER IN UNIVERSITY SYSTEM COLLABORATIVE R&D & IP ISSUES IN TECHNOLOGY TRANSFER IN UNIVERSITY SYSTEM Avinash Kumar Addl. Dir (IPR) DRDO HQ, DRDO Bhawan, Rajaji Marg New Delhi- 100 011 avinash@hqr.drdo.in IPR Group-DRDO Our Activities

More information

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and

More information

Cherry AB. The most complete gaming company Partnering with entrepreneurs to explore exciting ideas

Cherry AB. The most complete gaming company Partnering with entrepreneurs to explore exciting ideas Cherry AB The most complete gaming company Partnering with entrepreneurs to explore exciting ideas CEO Anders Holmgren & CFO Christine Rankin Copenhagen 10 January 2018 Investment case Positive outlook

More information

Digital Identity. Workshop. Roland Berger Munich Office

Digital Identity. Workshop. Roland Berger Munich Office Digital Identity Workshop Roland Berger Munich Office 7 April 2017 We are looking forward to working with you in today's workshop Your Roland Berger hosts Sebastian Steger Stephan Janssens Sebastian Maus

More information

Robert A. Greising Partner

Robert A. Greising Partner Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising is a Partner in the

More information

OECD s Innovation Strategy: Key Findings and Policy Messages

OECD s Innovation Strategy: Key Findings and Policy Messages OECD s Innovation Strategy: Key Findings and Policy Messages 2010 MIT Europe Conference, Brussels, 12 October Dirk Pilat, OECD dirk.pilat@oecd.org Outline 1. Why innovation matters today 2. Why policies

More information

Asking Questions on Knowledge Exchange and Exploitation in the Business R&D and Innovation Survey

Asking Questions on Knowledge Exchange and Exploitation in the Business R&D and Innovation Survey Asking Questions on Knowledge Exchange and Exploitation in the Business R&D and Innovation Survey John Jankowski Program Director Research & Development Statistics OECD-KNOWINNO Workshop on Measuring the

More information

Fujitsu Laboratories R&D Strategy. April 4, 2008 Kazuo Murano, Ph.D. President Fujitsu Laboratories Ltd.

Fujitsu Laboratories R&D Strategy. April 4, 2008 Kazuo Murano, Ph.D. President Fujitsu Laboratories Ltd. Fujitsu Laboratories R&D Strategy April 4, 2008 Kazuo Murano, Ph.D. President Fujitsu Laboratories Ltd. Our Global R&D Laboratory Model for the 21st Century Science Einstein... Atomic Energy, Moon Landing

More information

Laser Surface Authentication TM : biometrics for documents and goods

Laser Surface Authentication TM : biometrics for documents and goods Laser Surface Authentication TM : biometrics for documents and goods Professor Russell Cowburn Professor of Nanotechnology, Department of Physics, Imperial College London, UK. Chief Technical Officer,

More information

Globalisation increasingly affects how companies in OECD countries

Globalisation increasingly affects how companies in OECD countries ISBN 978-92-64-04767-9 Open Innovation in Global Networks OECD 2008 Executive Summary Globalisation increasingly affects how companies in OECD countries operate, compete and innovate, both at home and

More information

EU-India collaboration in the SME sector Turning environmental challenges into opportunities. 22 July 2010, New Delhi

EU-India collaboration in the SME sector Turning environmental challenges into opportunities. 22 July 2010, New Delhi EU-India collaboration in the SME sector Turning environmental challenges into opportunities 22 July 2010, New Delhi Agenda 1. small companies, Big Impact: EU SMEs ever increasing role in innovation &

More information

Facilitating Technology Transfer and Management of IP Assets:

Facilitating Technology Transfer and Management of IP Assets: Intellectual Property, Technology Transfer and Commercialization Facilitating Technology Transfer and Management of IP Assets: Thailand Experiences Singapore August 27-28, 2014 Mrs. Jiraporn Luengpailin

More information

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Financing Emerging Growth Companies

Financing Emerging Growth Companies Financing Emerging Growth Companies July (8,15,22) 2005 Ravi Sinha/Wilson Zehr Portland State University School of Business July 8, 2005 1:00 1:50 Class overview, review syllabus, grading, case studies

More information

Country Profile: Israel

Country Profile: Israel Private Interaction in the Decision Making Processes of Policies Country Profile: Israel 1. Political, institutional and economic framework and important actors Israel s National Science and Innovation

More information

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models Topic 4 Building a Competitive Edge: Protecting Inventions by Patents and Utility Models Training of Trainer s Program, Teheran 8 June 2015 By Matthias Kuhn, MBA University of Geneva, Unitec, Switzerland

More information

Dr Angela Maxwell OBE. Curriculum Vitae

Dr Angela Maxwell OBE. Curriculum Vitae Dr Angela Maxwell OBE Curriculum Vitae Personal Profile A highly energetic, dynamic and positive person with strong leadership, communication and influencing skills. A pragmatic businesswoman with sound

More information

British Business Bank

British Business Bank British Business Bank Lewis Stringer, MEIF Senior Relationship Manager UKSPA Summer Conference, University of Lincoln 7 th June 2018 The British Business Bank The UK s national economic development bank

More information

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

At the forefront of Abu Dhabi s economic diversification. August 2008

At the forefront of Abu Dhabi s economic diversification. August 2008 At the forefront of Abu Dhabi s economic diversification August 2008 Mubadala was established by the Government transformation of Abu Dhabi. to help drive the situation analysis 4 HIGH 3 Financial Return

More information

Regional innovation strategies: the Apulian experience and the role of ARTI, the Regional Agency for Technology and Innovation

Regional innovation strategies: the Apulian experience and the role of ARTI, the Regional Agency for Technology and Innovation Achieving Regional Innovation: Innovative Regions for Growth Regional innovation strategies: the Apulian experience and the role of ARTI, the Regional Agency for Technology and Innovation Annamaria Monterisi

More information

Venture Capital Search Highlights

Venture Capital Search Highlights Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure HOTELS, TOURISM & LEISURE nem is one of Australasia s largest boutique business consultancy firms, which is able to draw on the significant skills and experience of over 50 partners across Australia and

More information

Prof. Laura Lechuga Prof. Ángel Maquieira Prof. Rosa Puchades Dra. Maria J. Bañuls

Prof. Laura Lechuga Prof. Ángel Maquieira Prof. Rosa Puchades Dra. Maria J. Bañuls Dr. Miguel Holgado Dr. Carlos A. Barrios Dra. María Fé Lagunas Dr. Carlos Molpeceres Dr. Miguel Morales Ing. Juan Francisco Arquero Ing. Rafael Casquel del Campo Ing. F. Javier Sanza Rodriguez Prof. Laura

More information

COMMERCIAL INDUSTRY RESEARCH AND DEVELOPMENT BEST PRACTICES Richard Van Atta

COMMERCIAL INDUSTRY RESEARCH AND DEVELOPMENT BEST PRACTICES Richard Van Atta COMMERCIAL INDUSTRY RESEARCH AND DEVELOPMENT BEST PRACTICES Richard Van Atta The Problem Global competition has led major U.S. companies to fundamentally rethink their research and development practices.

More information

OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS

OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS Nataliia Revutska, Assistant Prof. Taras Shevchenko National University of Kyiv, Ukraine Abstract The paper considers the characteristics of two

More information

Change the Game, SMEs! Leverage on your IP

Change the Game, SMEs! Leverage on your IP WHY YOU SHOULD ATTEND The World IP Day, held on 26 April annually, is an international event established by the World Intellectual Property Organisation to celebrate IP's role in encouraging innovation

More information

Robert A. Greising Partner

Robert A. Greising Partner Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising serves as a Partner

More information

Getting Started. This Lecture

Getting Started. This Lecture Getting Started Entrepreneurship (MGT-271) Lecture 9-11 This Lecture Intellectual Property Rights Forms of intellectual property Patent, its types and steps to obtaining patent Potential financing sources

More information

Intellectual Property and the Commercialisation Process. An Overview

Intellectual Property and the Commercialisation Process. An Overview Intellectual Property and the Commercialisation Process An Overview Intellectual Property is wealth The product of your mind or intellect you create new IP every day Intangible in nature Exists in several

More information

Industrial Partnerships and Technology Transfer. Celine Serrano Transfer and Innovation Department

Industrial Partnerships and Technology Transfer. Celine Serrano Transfer and Innovation Department 1 Industrial Partnerships and Technology Transfer Celine Serrano Transfer and Innovation Department INRIA in numbers 2 A public research institute which has celebrated 40 years in 2007 A focus on ICT 3800

More information

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has

More information

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

IN-DEPTH ASSESSMENT OF THE SITUATION (CONTRACT NO ENTR/2010/16, LOT 2) Task 6: Research, Development and Innovation in the Footwear Sector

IN-DEPTH ASSESSMENT OF THE SITUATION (CONTRACT NO ENTR/2010/16, LOT 2) Task 6: Research, Development and Innovation in the Footwear Sector IN-DEPTH ASSESSMENT OF THE SITUATION OF THE EUROPEAN FOOTWEAR SECTOR AND PROSPECTS FOR ITS FUTURE DEVELOPMENT (CONTRACT NO ENTR/2010/16, LOT 2) Task 6: Research, Development and Innovation in the Footwear

More information

SMEs and European Programmes: opportunity or fatal attraction? Marco d Angelantonio CEO - HIM SA

SMEs and European Programmes: opportunity or fatal attraction? Marco d Angelantonio CEO - HIM SA SMEs and European Programmes: opportunity or fatal attraction? Marco d Angelantonio CEO - HIM SA HIM: A network of SMEs totally dedicated to ehealth and einclusion GdA MdA 10% 90% HIM Ltd - UK >0,023 %

More information

Technology Transfer at CERN

Technology Transfer at CERN Technology Transfer at CERN Enrico Chesta Head of CERN Technology Transfer and Intellectual Property Management Section Knowledge Transfer Group, FP Department How can CERN have an impact beyond fundamental

More information

From FP7 towards Horizon 2020 Workshop on " Research performance measurement and the impact of innovation in Europe" IPERF, Luxembourg, 31/10/2013

From FP7 towards Horizon 2020 Workshop on  Research performance measurement and the impact of innovation in Europe IPERF, Luxembourg, 31/10/2013 From FP7 towards Horizon 2020 Workshop on " Research performance measurement and the impact of innovation in Europe" IPERF, Luxembourg, 31/10/2013 Lucilla Sioli, European Commission, DG CONNECT Overview

More information

The business of Intellectual Property

The business of Intellectual Property The business of Intellectual Property Including IP patent value funds 15 th September 2008 Julian Nolan Julian Nolan - background Applications Engineer National Instruments, USA Business Development Director

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Activities on Business, Academia and Government collaboration Fund in Tohoku Region, (Tohoku Incubation Fund)

Activities on Business, Academia and Government collaboration Fund in Tohoku Region, (Tohoku Incubation Fund) Activities on Business, Academia and Government collaboration Fund in Tohoku Region, (Tohoku Incubation Fund) 6 February, 2006 Regional Cluster Seminar - For revitalization of Tohoku economy - Tohoku Innovation

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

Speed Innovation Happiness. Corporate Overview

Speed Innovation Happiness. Corporate Overview Corporate Overview Contents Bilcare Overview Businesses Business Strategy Financial Overview 2 Bilcare Overview 3 Bilcare Overview Our Objective Vision Delivering Innovation Transforming Lives Values Speed

More information

Investing in Regional Sustainability Norris Lozano, PDC

Investing in Regional Sustainability Norris Lozano, PDC Investing in Regional Sustainability Norris Lozano, PDC Regional Leaders Seminar Series Institute of Metropolitan Studies Portland, OR May 10, 2004 1 The Portland Development Commission Housing Infrastructure

More information

Accelerating Collective Innovation: Investing in the Innovation Landscape

Accelerating Collective Innovation: Investing in the Innovation Landscape PCB Executive Forum Accelerating Collective Innovation: Investing in the Innovation Landscape How a Major Player Uses Internal Venture Program to Accelerate Small Players with Big Ideas Dr. Joan K. Vrtis

More information

IDEO PROJECT. Venture Capital & Private Equity LATVIA

IDEO PROJECT. Venture Capital & Private Equity LATVIA IDEO PROJECT Venture Capital & Private Equity LATVIA PROBLEM: COMPANIES LACK EQUITY Benefits from venture capital and private equity to Latvian businesses, government and investors 3 Benefits to Latvian

More information

Technology transfer and development: implications of four case studies Session 2

Technology transfer and development: implications of four case studies Session 2 Technology transfer and development: implications of four case studies Session 2 Short courses for Permanent Missions in Geneva Monday, 15 December 2014 Michael Lim Policy Review Section Division on Technology

More information

2018 1Q IR PRESENTATION

2018 1Q IR PRESENTATION 2018 1Q IR PRESENTATION Investor Relation March 2018 Disclaimer These materials have been prepared by GRAVITY Co., Ltd. ("Gravity" or the "Company"). The statements contained in this presentation have

More information

Horizon 2020 and Photonics

Horizon 2020 and Photonics Brussels, 13 December 2013 Horizon 2020 and Photonics Thomas Skordas Head of the Photonics Unit, DG CONNECT European Commission Thomas.Skordas@ec.europa.eu Horizon 2020 Horizon 2020 Budget: 78.6 B (in

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Top 50 Emerging Technologies & Growth Opportunities

Top 50 Emerging Technologies & Growth Opportunities Top 50 Emerging Technologies & Growth Opportunities Multi-billion Dollar Technologies Ready to Energize Industries and Transform our World THE VALUE PROPOSITION TechVision s annual Top 50 Emerging Technologies

More information

2010/IPEG/SYM/003 Measures for Encouraging Patent Licensing - INPIT Challenges

2010/IPEG/SYM/003 Measures for Encouraging Patent Licensing - INPIT Challenges 2010/IPEG/SYM/003 Measures for Encouraging Patent Licensing - INPIT Challenges Submitted by: Japan Innovating Intellectual Property Exploitation Symposium Sendai, Japan 9 September 2010 September 9, 2010

More information

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

SMEC BUDGET 2017 RECOMMENDATIONS PRESS CONFERENCE 4 JANUARY 2017, WEDNESDAY. Opening Address by Mr Lawrence Leow, Chairman of SMEC

SMEC BUDGET 2017 RECOMMENDATIONS PRESS CONFERENCE 4 JANUARY 2017, WEDNESDAY. Opening Address by Mr Lawrence Leow, Chairman of SMEC Page 1 of 6 SMEC BUDGET 2017 RECOMMENDATIONS PRESS CONFERENCE 4 JANUARY 2017, WEDNESDAY Opening Address by Mr Lawrence Leow, Chairman of SMEC Ms Sim Ann, Senior Minister of State, Ministry of Culture,

More information

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Embracing Open Title Innovation Platforms

Embracing Open Title Innovation Platforms Embracing Open Title Innovation Platforms Sub-title Not all the smart people work for us. We need to work with smart people inside and outside the company.» Chesbourgh PLACE PARTNER S LOGO HERE European

More information

Career Pathways Talk - 28 July 2016 (Thursday) 2015 ISCA

Career Pathways Talk - 28 July 2016 (Thursday) 2015 ISCA Career Pathways Talk - 28 July 2016 (Thursday) Commercial Accounting Charles Ng Group Finance Director, Club 21 Charles is the Group Finance Director of a high-end lifestyle company with business operations

More information

Presentation. March 2007

Presentation. March 2007 Presentation March 2007 1 Corporate Overview 2 Corporate Overview Leading provider of research-driven packaging solutions solely-focused on pharmaceutical industry Founded in 1994 and based in Pune, India

More information

Notes from a seminar on "Tackling Public Sector Fraud" presented jointly by the UK NAO and H M Treasury in London, England in February 1998.

Notes from a seminar on Tackling Public Sector Fraud presented jointly by the UK NAO and H M Treasury in London, England in February 1998. Tackling Public Sector Fraud Notes from a seminar on "Tackling Public Sector Fraud" presented jointly by the UK NAO and H M Treasury in London, England in February 1998. Glenis Bevan audit Manager, Audit

More information

SMEs. Access to finance for. Screening Process with Serbia - Chapter 20. SME Access to Finance Directorate-General for Enterprise and Industry

SMEs. Access to finance for. Screening Process with Serbia - Chapter 20. SME Access to Finance Directorate-General for Enterprise and Industry Access to finance for SMEs Screening Process with Serbia - Chapter 20 SME Access to Finance Directorate-General for Enterprise and Industry Brussels 2 nd April 2014 Why EU intervention needed Action plan

More information

IEEE Boston Entrepreneurs Network. Raising Money from VCs. April 2012

IEEE Boston Entrepreneurs Network. Raising Money from VCs. April 2012 IEEE Boston Entrepreneurs Network Raising Money from VCs April 2012 Ascent Venture Partners Who we are Investment team of six, dedicated to investing in IT innovation for the enterprise Supporting early-stage

More information

IM - Innovation Management

IM - Innovation Management Coordinating unit: Teaching unit: Academic year: Degree: ECTS credits: 2017 295 - EEBE - Barcelona East School of Engineering 732 - OE - Department of Management BACHELOR'S DEGREE IN ELECTRICAL ENGINEERING

More information

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

NEW YORK UNIVERSITY Stern School of Business

NEW YORK UNIVERSITY Stern School of Business NEW YORK UNIVERSITY Stern School of Business Spring Term 2005 Investment Banking and Private Equity in Entertainment and Media Instructors: Stephen Finkel, Credit Suisse First Boston Philip Grovit, Goldman

More information